Spots Global Cancer Trial Database for Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
Official Title: Is VEGF a Useful Serum Biomarker for Patients Diagnosed With Meningioma or Glioma?
Study ID: NCT00985036
Interventions
Study Description
Brief Summary: Objectives: This study is looking at the level of vascular endothelial growth factor (VEGF) circulating in the blood stream of patients diagnosed with either a meningioma or a glioma. The questions that will be addressed include: 1. Can VEGF level alert us to tumor progression or recurrence before MRI changes occur? 2. Is the VEGF level an indicator of the response to treatment? 3. Does the VEGF level correlate with tumor histology and behavior? 4. Is there a relationship between VEGF level and outcome?
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Marquette General Hospital, Marquette, Michigan, United States
Contact Details
Name: Richard A Rovin, MD, FACS
Affiliation: Upper Michigan Brain Tumor Center
Role: PRINCIPAL_INVESTIGATOR
Name: Robert J Winn, PhD
Affiliation: Northern Michigan University
Role: PRINCIPAL_INVESTIGATOR
Name: Suresh Nukala, MD
Affiliation: Marquette General Health Systems
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
